Myasthenia gravis is a rare neuromuscular disorder characterized by muscle weakness and
fatigue. This review analyzes the most recent evidence regarding the effectiveness and …

The positive outcome of different therapeutic approaches for spinal muscular atrophy (SMA)
in clinical trials and in clinical practice have highlighted the need to establish if functional …

Hereditary motor and sensory neuropathy (HMSN) and myotonic dystrophy (MD) are chronic
neuromuscular diseases that cause progressive muscular impairment and impact patient's …

Introduction Slowly progressive, genetic neuromuscular diseases (gNMDs) often lead to
important motor deficiencies and functional limitations. The Quality of Life in Genetic …

Background To understand the health-related quality of life (HRQoL) in inclusion body
myositis (IBM) from a holistic perspective on the background of a complex care situation. The …

Purpose: Patients with spinal muscular atrophy (SMA) suffer from slowly progressive
weakness of axial, respiratory and proximal muscles, leading to restrictions in activity and …

Muscular dystrophy (MD) is a group of neuromuscular diseases characterized by
progressive muscle weakness due to various mutations in several genes involved in muscle …

Background High quality care of patients with neuromuscular diseases requires a
personalised approach that focuses on achieving and maintaining a level of functioning that …

Background and Objectives: Children with juvenile myasthenia gravis have a variety of
symptoms, ranging from isolated intermittent ocular complaints to overall muscle weakness …

Metode: V slovenščino smo prevedli vprašalnik ter preverili njegovo zanesljivost in
veljavnost. Funkcijsko stanje bolnikov smo ocenili z Lestvico funkcijske neodvisnosti …